Details for New Drug Application (NDA): 021152
✉ Email this page to a colleague
The generic ingredient in CUTIVATE is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 021152
Tradename: | CUTIVATE |
Applicant: | Fougera Pharms |
Ingredient: | fluticasone propionate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Mar 31, 2005 | TE: | RLD: | Yes |
Expired US Patents for NDA 021152
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Fougera Pharms | CUTIVATE | fluticasone propionate | LOTION;TOPICAL | 021152-001 | Mar 31, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription